Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
98.93
(
-0.93%
)
Bitcoin
70,956.84
(
0.26%
)
News Focus
News Focus
Post# of 257392
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122862
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 249743

Thursday, 03/21/2024 5:12:47 PM

Thursday, March 21, 2024 5:12:47 PM

Post# of 257392
GRPH—>LENZ effective at tomorrow’s open, pursuant to previously announced reverse-merger:

https://www.businesswire.com/news/home/20240321281097/en

I’m generally bearish on the commercial prospects for a presbyopia eyedrop that works by inducing pupil contraction, and LENZ is not the only company developing such a product.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today